Just When You Thought Meta Tags Were Safe, Along Comes Twitter’s “Ad Card”
You might recall this post I made three years ago: "Who's in Charge of Your 'Invisible' Metadata? WARNING: Don't Invoke the 'Invisibility Rule'".
In that...
Pharma and Social Media – Comfy Bedfellows: Boehringer, AstraZeneca, & Janssen Get It On!
This article reviews social media breakthroughs by Boehringer, AstraZeneca, & Janssen.
Mobile Apps Track Sunshine Payments: Will They Help Reduce Disputes?
This article is a review of CMS's OpenPayments App for Physicians and Industry.
Physicians Under Pharma’s Influence: Are Physicians Powerless Pawns of Pharma Psychology?
Ethicists identify six 'principles of influence' that are key to the drug industry’s routine marketing strategies, which rely on the illusion that the industry is a generous avuncular partner to physicians.
Pharma Marketing News Vol. 12, No. 7: 9 September 2013
Welcome to Volume 12, Issue #7 (9 September 2013) of Pharma Marketing News.
Pharma Marketing News Vol. 12, No. 7: 9 September 2013
Welcome to Volume 12, Issue #7 (9 September 2013) of Pharma Marketing News.
Is Your TweetChat “Regulation Safe?” Regulators Should Publish Opinions on Specific Social Media Initiatives...
Yesterday, I cited a bit of ABPI code of Practice in relation to Boehringer's #COPDChat: "Using twitter to alert health professionals about the publication...
Will Social Media Make it Harder for Pharma to “Hide” Drug Side Effects?
John LaMattina, former Pfizer president of Research and Development, suggests that FDA regulations make it virtually impossible for the pharmaceutical industry to "hide" drug...
Boehringer Takes My Advice and Will Host the First-Ever Disease Condition TweetChat: #COPDChat
Two-and-one-half years after AstraZeneca hosted the First-Ever pharma Twitter chat (see "OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End!"), Boehringer Ingelheim (BI)...
Janssen Engages HIV Community on Tumblr: Build It and They Will Come?
A few months ago, I engaged Peter Houston (@Flipping_Pages) in a discussion about whether or not pharma "should" do Tumblr, a social media site...
